Author Archives: achicotel

About achicotel

Anthony Chicotel is a staff attorney for CANHR. His areas of expertise include the rights of long-term care residents, nursing home litigation, health care decision-making, and conservatorships.

10 Things to Check Before Drugging

by Anthony Chicotel, CANHR Staff Attorney State and federal law define a nursing home chemical restraint as any drug used to control behavior and not required or necessary to treat the resident’s medical symptoms. Thus, if the resident’s symptoms could … Continue reading

Share

A Billion Here, a Billion There

by Anthony Chicotel, CANHR Staff Attorney When it comes to illegal marketing of mind-bending psychotropic drugs, the beat goes on.  In the past few weeks, Abbott Laboratories agreed to pay at least $1.3 billion to the U.S. and multiple state … Continue reading

Share

False Medical Records? Just Follow the “I.C.O.”

by Anthony Chicotel, CANHR Staff Attorney Last weekend’s Sacramento Bee articles about falsified nursing home records would certainly come as no shock to anyone familiar with the misuse of psychotropic drugs on residents. California nursing homes are charged with verifying … Continue reading

Share

Depressing News About Anti-Depressants

A Review of The Emperor’s New Drugs: Exploding the Antidepressant Myth by Irving Kirsch Are anti-depressants really just expensive placebo pills?  In a searing review of clinical studies involving anti-depressants, psychologist Irving Kirsch raises significant doubts about the efficacy of … Continue reading

Share

Senators Grassley and Kohl to CMS: Cut Drugs, Save Lives, Save Money

by Anthony Chicotel, CANHR Staff Attorney Senators Grassley and Kohl, the co-chairs of the U.S. Senate Special Committee on Aging recently wrote a letter to Center for Medicare Services’ Administrator Donald Berwick expressing new concerns about the role of nursing … Continue reading

Share

A Win-win for Care and for Costs

by Deborah Espinola, CANHR Advocate The Senate Special Committee on Aging recently issued a report recommending a reduction of the “needless prescription of dangerous drugs for nursing home residents” to cut national health care costs. (CANHR recommends eliminating needless dangerous drugs … Continue reading

Share

Untreated Pain a Likely Source of Dementia-Associated Agitation

By Anthony Chicotel, CANHR Staff Attorney Americans who decry the misuse of psychotropic drugs in long-term care facilities should be encouraged by the strides being made in England to promote non-pharmacological alternatives for “treating” dementia.  The British Medical Journal recently … Continue reading

Share

Nursing Home Doc Association Says Drugs Should Be Last Resort

by Anthony Chicotel, CANHR Staff Attorney I recently reviewed the American Medical Directors’ Association’s (AMDA) Clinical Practice Guide to dementia care in nursing homes. The Practice Guide presents a thoughtful, 18-step process for diagnosing and treating dementia in the long-term … Continue reading

Share

Harvard Doc Calls for Ban on Haldol

by Anthony Chicotel, CANHR Staff Attorney Dr. Louis Caplan, a neurology professor at Harvard Medical School, reacting to a recent government report of misuse of antipsychotic drugs on elderly nursing home residents, stated he “would love to see Haldol banned … Continue reading

Share

Johnson & Johnson – Next Billion Dollar Settlement?

by Tony Chicotel, CANHR Staff Attorney The Wall St. Journal is reporting that the U.S. Attorney’s Office is seeking a settlement of around $1 billion to resolve its investigation of illegal marketing tactics by Johnson & Johnson for its antipsychotic … Continue reading

Share